• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • High Throughput Layout and Copy Paste July 5, 2019
  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

IPILIMUMAB

Immune checkpoint blockade in cancer immunotherapy

August 28, 2018Cancer, Cancer Immunotherapy, Vizit Graphs
Immune checkpoint blockade in cancer immunotherapy

Explore immune checkpoint blockade (PD-1, CTLA-4) in cancer immunotherapy with Biovista Vizit. Explore the live graph.

Vizit Graphs Tag Cloud

FOXP3 RHEUMATOID ARTHRITIS PSEUDOMONAS AERUGINOSA BREAST CANCER APOPTOTIC PROCESS CD4 NEURODEGENERATIVE DISORDERS CELL PROLIFERATION ANGIOGENESIS PORPHYROMONAS GINGIVALIS IL6 IFNG AGING SOD1 RECEPTOR METFORMIN ALZHEIMER'S DISEASE PARKINSON DISEASE DOXORUBICIN CELL DEATH HELICOBACTER PYLORI TH17 CELLS TNF CELL DIVISION AUTOPHAGY CLOSTRIDIUM DIFFICILE ESCHERICHIA COLI IMMUNE RESPONSE REMICADE CASP3 IL23A INFLAMMATION CELL DIFFERENTIATION CANCER LISTERIA MONOCYTOGENES IL17A CANDIDA ALBICANS STAPHYLOCOCCUS AUREUS INSULIN STREPTOCOCCUS PNEUMONIAE DIABETES MELLITUS 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE ERBB-2 CTLA4 TP53

© 2019 Biovista Vizit All Rights Reserved.